Back to Industry News
General

Australia Invests $13.6M to Strengthen Clinical Trials; AusBiotech Applauds

Heartspace News Desk
Source: Biotech Dispatch
TL;DR

The Australian life sciences sector will receive $13.6 million from the Albanese Government to improve national health and medical research. This investment will establish a National One Stop Shop for clinical trials, create national standard operating procedures, and implement the National Clinical Trials Governance Framework nationwide.

Key takeaways

  • The Australian life sciences sector is poised to receive a significant boost with a $13
  • 6 million investment from the Albanese Government
  • According to Biotech Dispatch, this funding aims to advance national health and medical research reforms by supporting the creation of a National One Stop Shop for clinical trials, developing national standard operating procedures, and implementing the National Clinical Trials Governance Framework nationwide
The Australian life sciences sector is poised to receive a significant boost with a $13.6 million investment from the Albanese Government. According to Biotech Dispatch, this funding aims to advance national health and medical research reforms by supporting the creation of a National One Stop Shop for clinical trials, developing national standard operating procedures, and implementing the National Clinical Trials Governance Framework nationwide. AusBiotech CEO Rebekah Cassidy hailed the reform as a "once-in-a-generation opportunity." However, she emphasized the importance of a unified, whole-of-government strategy for the life sciences industry, pointing out that current policy oversight is fragmented across nine government portfolios.

Related Topics

clinical trialsAustraliaAusBiotechfundinglife sciencesresearchgovernment investment

Share Your Thoughts

(0 comments)

Be the first to share your thoughts on this article!

Stay Updated

Create alertsRead original